When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis-Reference-Cited by-同舟云学术

When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis

Published:2024-01-10 Issue:2 Volume:53 Page:155-157
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Yoo W-H¹²^ORCID,Ha GW²³^ORCID,Kim KM²⁴^ORCID,Choi Y¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Rheumatology, Jeonbuk National University Medical School, Jeonju, South Korea

2. Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea

3. Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Korea

4. Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea

Funder

National Research Foundation of Korea

Korean government Ministry of Science and ICT

Jeonbuk National University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2023.2294580

Reference9 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

2. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

3. World Health Organization. WHO coronavirus (COVID-19) dashboard. [cited 2023 Sep 26]. Available from: https://covid19.who.int/.

4. Gastrointestinal manifestations of COVID-19: An updated systematic review

5. Gastrointestinal perforation secondary to COVID-19